OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

An announcement is apparently imminent (unconfirmed source)- I should think a Bid from a Major Pharmaceutical Co at well over 30p

it will go to 30p without a bid...a bid would worth much more.

Yes, I think so too, remember this share went to 1.32 in 2000, I'm not saying that means anything but it shows the volatility and difficulty in "valueing" a co and a lot has happened since, the co has strengthened and their trials have progressed well/licence deals etc. how can you put a value on it, the market for Trovax is supposedly worth billions although they're a few yrs off that, but then there's all the other products being developed - for Parkinsons, Aids, the list goes on. large Pharmaceuticals are surely working the figures at the moment- a bidding war may ensue. Some analysts have put a value of 50p on Trovax alone so we shouldn't sell out at this pitiful sp.

Small Talk: Signs point to Vernalis as OXB's mystery suitor
Emerging floats; Stock-pickers' guide; M&B to the rescue; Diesel firm splutters
By Stephen Foley
24 January 2005


There's nothing like the admission of bid talks to pep up a stagnant share price, and Oxford BioMedica, a gene therapy company with a couple of cancer drugs in the pipeline, was last week's best-performing small-cap share after admitting it had received "an approach".

The public statement was forced on the company after speculators got whiff that something was up and piled into the stock. Wild talk on the bulletin boards is still predicting a 30p-per-share cash bid from a large pharmaceutical company or a much bigger biotech specialist from continental Europe or the US - despite the fact that OXB's statement referred to the possible deal as a "merger".

Bulls reckon the word merger is a face-saver, often employed by small companies who are being taken over, but Small Talk hears that the word was chosen very carefully. The shares, at 22.75p, look vulnerable if the reality turns out to be a mundane all-share combination with a not-much-bigger biotech close to home.

Which is why Small Talk is worried (for the speculators) that the approach might have come from Vernalis, the former British Biotech, which is back on the acquisition trail after sorting out marketing problems with its main drug last year. The company won't rule itself in or out as the bidder, but the respected analysts at Evolution Securities, adding their own "fuel to the bonfire of speculation", have come to the same guess.

Vernalis, chaired by Peter Fellner, has grand plans to consolidate a UK biotech sector that is still characterised by sub-scale players with too few drugs, too little money and too-high losses. OXB's cancer products would bolster Vernalis's own pipeline in this area, but there is also a useful fit between OXB's more experimental work in Parkinson's disease and the Vernalis pipeline in neurology.

Vernalis itself is optimistic about 2005, since it recently signed a new marketing partner for its migraine drug, Frova.



http://news.independent.co.uk/business/analysis_and_features/story.jsp?story=603993


wilbs

What sort of nonsense is that "Wild Talk" - what's wild about valueing a co with potential blockbusting income earning drugs at a poultry 100m. They should do their research, this time last yr they were higher than that. A takeover would never go through at theselevels and a merger is just not in the interests of shareholders or the Kingsmans.

Agree. A good buying oppportunity at these levels. Obviously if a bid does not materialise then the sp will sink back down, but aren't we missing the wider picture, that the share has been undervalued for too long and should be much higher on the strength of the progress made and not just on bid speculation. Last yr they were tipping this to go to 50p so why is 30 p so wild? Foley's record is not so hot anyway.

Someone has been buying big time this morning.

Someone's bought 6million shares at over 22p, stake building?

Morning All

Appears that Boris Johnson did not read 'The Independent' Newspaper Article yesterday and is carrying on building up a large stake in OXB.
It will be interesting to see what happens to the share price over the next month and to see whether 30p per share price is 'wild talk' on bulletin boards or whether that is a low estimate.
The FT over the weekend stated that OXB had recieved a 'takeover' bid while other newspapers such as 'The Independent' state that OXB are in merger talks. I think the company (OXB) should clarify more clearly the type of approach that they recieved.
Like others on this board I reckon that 30p per share is quite easily achievable in the short-term and will continue to hold the stock and see what happens. My only regret is that I cannot afford to increase my present holding.

The stake building in OXB is still continuing today. The following group's have been purchasing holdings since the 21st Jan 05.

Lazard&Co (Panmure Gordon), Sputnik Group Ltd, Garboldi Investment Ltd, Sulidad Investment& Trade Inc, Credit Agricole S.A. and Man Financial Ltd.

With all the large trades going through over the last few days I cannot understand why the share price has not continued moving upwards this week.

Any comments welcome.

170 - how do you know that those institutions have been increasing their stake in OXB since 21 st Jan?

Pachandl

Please clink on the Growth Company Investor website and enter in the OXB symbol. You will be able to read the company announcements of the above groups who have made investments since the 21st January 2005.

1704 Thanks.

Pachandi Thanks, V. Interesting. Have bought and sold some at profit. But have a hold now at profit would be nice to see 30p

1704 - presumably you are a subscriber? I am not!

Pachandl

I am a subscriber of the service and recieve a monthly magazine which comments on all the sectors,provides useful analysis on small companies and regular share tips. I also fimd the website a useful tool for showing information on small companies. The service will not be to everyone's taste but personally I would recommend it. Subscrition rates are not expensive neither. I hope I can apply for commission for this?

Over the last 2 weeks I have bought and sold at profit and bought back in again. Its a risk I think is worth taking. One of my earlier posts today lists a number of large investors adding to their holdings in OXB over the last few days. Have they heard something we have not? As a result the share price has slightly ticked up upwards today. I hope it continues to do so.

Ticking up gradually, 30p is not far off and a bid would certainly have to be much higher if it's to succeed. This co has been undervalued and big investors are finally realising the potential. As I have said before, there are many that would want OXB for Trovax alone and this has been valued at 50p before.

more very large buys this a.m.

Detailed Technical Analysis on OXB (26th January 2005)

Short Term Commentary-'The stock's short term strength is ascending rapidly. The price is in a rally, we will now let the profits run'.

Medium Term Commentary-Medium term price trend OXB change from bearish to bullish this week. This market keeps a relative behavior greater 30.23 than FTSE 100 INDEX. Volatility has been increasing during last month.

Performance Summary: Since 31/12/04 (31.4286%)
Since Last Week (19.4805%)
Share Price Support Level (17p)
Share Price Resistance Level (97.25p)

Please do not take my word for these above comments click on the Yahoo Finance website and view for yourself.

Any comments welcome.

Morning All!

Seems like some of the large investors who have been adding to their stakes in OXB over the last week are speculating that the share price has further upwards momentum in the short and medium term.

According to the Yahoo Finance Website (Detailed Technical Analysis on OXB)
30p per share is a conservative estimate. It would be great if this proves case. Anything above 30p would be good, 35p a bonus and 40p lovely jubbly.